Related Experiment Video
Updated: Feb 18, 2026
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
Chemotherapy-Induced Depletion of OCT4-Positive Cancer Stem Cells in a Mouse Model of Malignant Testicular Cancer
Timothy M Pierpont1, Amy M Lyndaker1, Claire M Anderson1
1Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Abstract:
Testicular germ cell tumors (TGCTs) are among the most responsive solid cancers to conventional chemotherapy. To elucidate the underlying mechanisms, we developed a mouse TGCT model featuring germ cell-specific Kras activation and Pten inactivation. The resulting mice developed malignant, metastatic TGCTs composed of teratoma and embryonal carcinoma, the latter of which exhibited stem cell characteristics, including expression of the pluripotency factor OCT4. Consistent with epidemiological data linking human testicular cancer risk to in utero exposures, embryonic germ cells were susceptible to malignant transformation, whereas adult germ cells underwent apoptosis in response to the same oncogenic events. Treatment of tumor-bearing mice with genotoxic chemotherapy not only prolonged survival and reduced tumor size but also selectively eliminated the OCT4-positive cancer stem cells. We conclude that the chemosensitivity of TGCTs derives from the sensitivity of their cancer stem cells to DNA-damaging chemotherapy.
Insights
Testicular germ cell tumors (TGCTs) are highly responsive to chemotherapy. This study reveals that chemotherapy effectively targets cancer stem cells in TGCTs, explaining their sensitivity.
Area of Science:
- Oncology
- Cancer Biology
- Developmental Biology
Background:
- Testicular germ cell tumors (TGCTs) are highly chemosensitive solid cancers.
- Understanding the mechanisms behind TGCT chemosensitivity is crucial for improving cancer treatment.
- Cancer stem cells (CSCs) are implicated in tumor resistance and recurrence.
Purpose of the Study:
- To elucidate the mechanisms underlying the chemosensitivity of testicular germ cell tumors.
- To investigate the role of cancer stem cells in TGCT development and treatment response.
- To establish a preclinical mouse model for studying TGCT pathogenesis and therapeutic strategies.
Main Methods:
- Development of a genetically engineered mouse model with germ cell-specific Kras activation and Pten inactivation.
- Histopathological analysis of tumors to characterize teratoma and embryonal carcinoma components.
- Assessment of stem cell characteristics, including OCT4 expression, in tumor cells.
- Evaluation of chemotherapy response in tumor-bearing mice, focusing on tumor size, survival, and CSC elimination.
Main Results:
- The developed mouse model recapitulated malignant, metastatic TGCTs with teratoma and embryonal carcinoma components.
- Embryonic germ cells were susceptible to malignant transformation, while adult germ cells underwent apoptosis.
- OCT4-positive cancer stem cells were identified within the embryonal carcinoma component.
- Genotoxic chemotherapy significantly reduced tumor burden, prolonged survival, and selectively eliminated OCT4-positive CSCs.
Conclusions:
- The chemosensitivity of TGCTs is attributed to the sensitivity of their cancer stem cells to DNA-damaging chemotherapy.
- Targeting cancer stem cells represents a promising therapeutic strategy for TGCTs.
- The mouse model provides a valuable platform for future research into TGCT biology and treatment.
